Lucid Diagnostics, Inc. (LUCD)
0.83
-0.07
(-7.45%)
USD |
NASDAQ |
Sep 09, 15:01
Lucid Diagnostics Debt to Equity Ratio : 2.280 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.280 |
| March 31, 2026 | 6.701 |
| December 31, 2025 | 2.361 |
| September 30, 2025 | 0.9419 |
| June 30, 2025 | 3.505 |
| March 31, 2025 | -6.559 |
| December 31, 2024 | 3.942 |
| September 30, 2024 | 2.062 |
| June 30, 2024 | 0.891 |
| March 31, 2024 | 1.192 |
| December 31, 2023 | -6.601 |
| September 30, 2023 | 6.292 |
| June 30, 2023 | 0.8918 |
| March 31, 2023 | 0.5532 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0867 |
| September 30, 2022 | 0.0727 |
| June 30, 2022 | 0.0574 |
| March 31, 2022 | 0.0478 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.9281 |
| June 30, 2021 | -1.123 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| PAVmed, Inc. | 0.487 |
| Alphatec Holdings, Inc. | 52.37 |
| Electromed, Inc. | 0.0025 |
| Pulse Biosciences, Inc. | 0.0681 |
| Abbott Laboratories | 0.638 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 38.95M |
| Total Liabilities (Quarterly) | 28.02M |
| Shareholders Equity (Quarterly) | 10.93M |
| Current Ratio | 1.331 |
| Net Debt Paydown Yield | 1.02% |